Targeting mutant TNNT2-induced epigenetic perturbation and pathogenic signaling in left ventricular non-compaction cardiomyopathy

You-Yi Li,Wei-Chieh Tseng,Hua-Ling Kao,Yu-Shin Shie,Shuenn-Nan Chiu,Ya-Ting Wu,Chung-Ming Sun,Shiou-Ru Tzeng,Liang-Chuan Lai,Miao-Hsia Lin,Yen-Wen Wu,Kuan-Yin Ko,Jyh-Ming Jimmy Juang,Ryan Hsieh,Mei-Hwan Wu,Wen-Pin Chen,Hong-Nerng Ho

DOI: https://doi.org/10.1101/2024.10.09.24314670

2024-10-11

Abstract:Background Compound mutations of TNNT2R141W/+ (encoding troponin T) and MYPNS1296T/+ (encoding myopalladin) are associated with familial left ventricle non-compaction cardiomyopathy (LVNC). However, it remains unclear in which would be the pathogenic mutation, the underlying mechanism, and the target therapy for LVNC. Methods Knock-in C57BL/6J mice harboring mutations in orthologous genes in Tnnt2R154W or/and MypnS1291T and human cardiomyocytes derived from iPSC of healthy donors and LVNC patients (LVNC-hCM) were employed for disease modeling, omics analysis, mechanistic study, and drug development. Results Using knock-in mice for disease modeling, it was clarified that the orthologous mutation in Tnnt2, but not in Mypn, led to cardiac hypertrabeculation, noncompaction, and heart failure. 3D protein structure modeling by Swiss-model found a loss of slat bridge between TNNT2(R141W) and E-257 in tropomyosin, contributing to the decreased cardiac contraction. Further mechanistic study discovered that troponin T (TNNT2) appears to function as an HDAC1 sponge in cardiomyocyte nuclei. The compromised association between nuclear TNNT2(R141W) and HDAC1 causes cardiac epigenetic perturbation and subsequentially leads to transcriptional dysregulation. The downregulation of cardiac muscular genes was concomitant with the impairment of cardiac contraction, which would be partially rescued by pan HDAC inhibitor. Besides, the upregulation of TGFβ-signaling molecules and EZH2 did contribute to cardiac growth defects, which were mitigated by TGFβR1 inhibitor (A83-01) and EZH2 inhibitor (GSK503), respectively. Simvastatin, a hit drug identified from the repurposed drug screening, can restore nuclear TNNT2(R141W)-HDAC1 association, thereby recovering cardiac epigenetic, translational profiles, growth and function in LVNC-hCM in vitro and cardiac function in LVNC mice harboring Tnnt2R154W in vivo. The cardiac function was significantly improved in the proband receiving 5 mg once daily for consecutive two years. Conclusion Mutant TNNT2(R141W) diminished its nuclear HDAC1 sponge function in cardiomyocyte to induce LVNC pathogenesis through perturbating cardiac epigenetic and the gene expressions. Targeting to HDAC, TGFβ, EZH2 may rescue part of cardiac pathological signaling. Simvastatin can act as a chemical chaperone to comprehensively recover cardiac epigenetic via restoring nuclear TNNT2(R141W)-HDAC1 association.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to clarify the specific pathogenic mutations that lead to familial left ventricular non - compaction cardiomyopathy (LVNC), the mechanisms behind them, and the possible treatment targets. Specifically, the study focused on the role of compound mutations of two gene mutations - TNNT2R141W and MYPNS1296T - in LVNC. Although these mutations are known to be related to LVNC, which one is the pathogenic mutation, what are the specific mechanisms, and how to treat according to these mechanisms are all issues that need further exploration. Through constructing mouse models carrying corresponding mutations, using human - induced pluripotent stem cell (hiPSC) technology, conducting omics analysis and drug screening, etc., the study aims to reveal how the TNNT2R141W mutation triggers LVNC by affecting cardiac epigenetic and gene expression, and explores potential treatment methods for signaling pathways such as HDAC, TGFβ and EZH2. The study also found that simvastatin can comprehensively restore the cardiac epigenetic state and improve the condition of LVNC patients by restoring the binding of TNNT2(R141W) - HDAC1 in the nucleus.

Targeting mutant TNNT2-induced epigenetic perturbation and pathogenic signaling in left ventricular non-compaction cardiomyopathy

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Elevated Myocardial SORBS2 and the Underlying Implications in Left Ventricular Noncompaction Cardiomyopathy

Sarcomere gene variants act as a genetic trigger underlying the development of left ventricular noncompaction

Allele-specific Differences in Transcriptome, Mirnome, and Mitochondrial Function in Two Hypertrophic Cardiomyopathy Mouse Models

Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes

Clinical Genetics and Outcome of Left Ventricular Non-Compaction Cardiomyopathy.

Phenotype And Functional Analyses In A Transgenic Mouse Model Of Left Ventricular Noncompaction Caused By A Dtna Mutation

Lineage-specific regulatory changes in the pathological cardiac remodeling of hypertrophy cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics

Establishing a New Human Hypertrophic Cardiomyopathy-Specific Model Using Human Embryonic Stem Cells

Functional Consequences of A Novel Cardiac Troponin T Mutation Linked to Infantile Restrictive Cardiomyopathy

Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant

Abstract P439: Harnessing Multiscale Models Of A Dilated Cardiomyopathy Mutation For Precision Medicine

A novel mutation in the TTN gene resulted in left ventricular noncompaction: a case report and literature review

Abstract 274: Activation of CaMKII Signaling Pathway Contributes to the Pathogenesis of Genetic Hypertrophic Cardiomyopathy

Harnessing molecular mechanism for precision medicine in dilated cardiomyopathy caused by a mutation in troponin T

Deficiency of nuclear receptor interaction protein leads to cardiomyopathy by disrupting sarcomere structure and mitochondrial respiration

Integrated single-cell RNA-seq analysis revealed PTN secreted by fibroblasts acting on itself and macrophages via SDC4 ligand in myocardial hypertrophy

Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1

Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy

Chronic Activation of Tubulin Tyrosination Improves Heart Function